The Bill Nobody Diagnoses: Why Financial Toxicity Deserves a Place on Every Foundation's Agenda
Photo: unknown photographer, published by Gordon Stationery & Bookstores Khartoum, Public domain, via Wikimedia Commons
There is a moment familiar to thousands of American families. The treatment is working. The specialists are excellent. The insurance company has approved the plan. And then the explanations of benefits arrive, one after another, and the arithmetic of survival begins: the out-of-network lab, the facility fee, the coinsurance that resets every January. The illness has a treatment plan. The debt does not.
We want to name this plainly: financial toxicity is a health crisis, and it deserves the same seriousness that foundations bring to the diseases that cause it.
When Cost Becomes Clinical
The term "financial toxicity" entered the medical literature for good reason. Researchers studying cancer patients — and more recently those with chronic and rare conditions — have documented that financial distress is not merely a side effect of illness. It is associated with treatment non-adherence, worse self-reported health, and higher rates of depression and anxiety. Families skip doses to stretch a prescription. They postpone follow-up imaging. They take second jobs at precisely the moment a child needs them most.
The scale is difficult to overstate. Medical debt remains the largest category of consumer debt in collections in the United States, and Americans with chronic illness bear a disproportionate share of it. Roughly 40 percent of adults report some difficulty covering a basic healthcare need. For the rare disease community, where specialized therapies can carry five- and six-figure annual price tags even with coverage, the exposure is starker still.
Insurance, in theory, is the answer. In practice, deductibles, coverage exclusions, network gaps, and prior authorization battles leave families exposed in ways that are predictable and, therefore, preventable. This is not an argument against insurance reform — it is urgently needed. But reform moves at the speed of legislation, and a family facing a $12,000 balance does not have the luxury of waiting for the next session of Congress.
Why Nonprofits Must Fill the Breach
Foundations occupy a unique position in American healthcare. We are nimble where institutions are slow, trusted where systems are distrusted, and accountable to communities rather than shareholders. If a family cannot access care because of cost, that is not adjacent to our mission. It is our mission.
Historically, many health nonprofits have treated patient assistance as a peripheral program — a nice-to-have funded by leftover dollars. We believe that framing is no longer defensible. A research grant that produces a therapy no family can afford is an incomplete victory. A support program that ignores the eviction notice on the kitchen table is addressing half the diagnosis.
What The Kristen Foundation Is Doing
We are not asking others to act without acting ourselves. Beginning this year, The Kristen Foundation is expanding its patient support commitments in three concrete ways.
First, we are growing our direct assistance grants for families managing the conditions at the center of our mission, with streamlined applications designed to deliver funds within weeks, not months — because a past-due notice does not respect grant cycles.
Second, we are funding navigation. Financial counseling, insurance appeal assistance, and help accessing manufacturer assistance programs can save families thousands of dollars, yet most families never learn these services exist. We will pay for navigators in the communities we serve and publish plain-language guides free of charge.
Third, we are committing to transparency and research on financial toxicity itself — documenting where families in our community face the greatest cost burdens so that our programs, and hopefully policymakers, can target them effectively.
An Invitation
None of this is possible without donors, and so we extend an honest invitation: when you give to The Kristen Foundation, you are funding more than research and more than hope. You are keeping a medication filled, an appointment kept, a family housed. Philanthropy in American healthcare has always stepped in where markets and policy fall short. Here, in the quiet emergency of medical debt, is where we believe it must step next.
Financial toxicity may not appear on any lab report. But it is real, it is measurable, and it is treatable — if we choose to treat it.
